The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis

Journal of Investigative Dermatology

Volumn 111, Issue 2, 1998, Pages 233-238

  Grichnik, James M ^a   Burch, James A ^a   Burchette, James ^a   Shea, Christopher R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HMB 45; K44.2; Mast cell growth factor; Xenograft

Indexed keywords

INTERLEUKIN 3; MONOPHENOL MONOOXYGENASE; STEM CELL FACTOR;

ARTICLE; CELL DENSITY; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; PRIORITY JOURNAL; SKIN GRAFT; XENOGRAFT;

EID: 0031927710     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00272.x     Document Type: Article

References (53)

1. Adema GJ, de Boer AJ, van't Hullenaar R, Denijn M, Ruiter DJ, Vogel AM, Figdor CG: Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 143:1579-1585, 1993
2. Berdel WE, de Vos S, Maurer J, et al: Recombinant human stem-cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52:3498-3502, 1992
3. Bernstein A, Forrester L, Reith AD, Dubreuil P, Rottapel R: The murine W/c-kit and steel loci and the control of hematopoiesis. Semin Hematol 28:138-142, 1991
4. Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, Yarden Y: Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. J Biol Chem 268:4399-4406, 1993
5. Blechman JM, Lev S, Barg J, et al: The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103-113, 1995
6. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo K, Westermark B, Heldin C: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 111:4121-4128, 1991
7. Bouchard B, Vijayasaradhi S, Houghton AN: Production and characterization of antibodies against human tyrosinase. J Invest Dermatol 102:291-295, 1994
8. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC, and The Children's Cancer Group: Expression of stem cell factor and c-kit in human neuroblastoma. Blood 84:3465-3472, 1994
9. Costa JJ, Demetri GD, Harrist TJ, et al: Recombinant human stein cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681-2686, 1996
10. Dai CH, Krantz SB, Zsebo KM: Human burst-forming units-erythroid need direct interaction with stem-cell factor for further development. Blood 78:2493-2497, 1991
11. Donatien P, Surlève-Bazeille J, Thody A, Taïeb A: Growth and differentiation of normal human melanocytes in a TPA-free, cholera toxin-free, low-serum medium and influence of keratinocytes. Arch Dermatol Res 285:385-392, 1993
12. Ezoe K, Holmes SA, Ho L, et al: Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet 56:58-66, 1995
13. Funasaka Y, Boulton T, Cobb M, et al: c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Bio Cell 3:197-209, 1992
14. Giebel LB, Spritz RA: Mutation of the KIT (mast/stem-cell growth factor receptor) protooncogene in human piebaldism. Proc. Natl Acad Sci USA 88:8696-8699, 1991
15. Gordon PR, Mansur CP, Gilchrest BA: Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol 92:565-572, 1989
16. Grichnik JM, Crawford J, Jimenez F, et al: Human recombinant stem cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol 33:577-583, 1995
17. Grichnik JM, Ali WN, Burch JA, Byers JD, Garcia CA, Clark RE, Shea CR: KIT reveals a population of precursor melanocytes in human skin. J Invest Dermatol 106:967-971, 1996
18. Halaban R, Moellmann G: White mutants in mice shedding light on humans. J Invest Dermatol 100:176S-185S, 1993
19. Hara M, Yaar M, Gilchrest BA: Endothelin-1 of keratinocyte origin is a mediator of melanocyte dendricity. J Invest Dermatol 105:744-748, 1995
20. Herlyn M, Shih I: Interaction of melanocytes and melanoma cells with the microenvironment. Pigment Cell Res 7:81-88, 1994
21. Hibi K, Takahashi T, Sekido Y, et al: Coexpression of the stem-cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6:2291-2296, 1991
22. Kiss C, Cesano A, Zsebo KM, Clark SC, Santoli D: Human stem-cell factor (c-kit ligand) induces an autocrine loop of growth in a GM-CSF-dependent megakaryocytic leukemia cell line. Leukemia 7:235-240, 1993
23. t mice with a Kit kinase-domain mutation. Proc Natl Acad Sci USA 89:7816-7820, 1992
24. Lassam N, Bickford S: Loss of c-kit expression in cultured melanoma cells. Oncogene 7:51-56, 1992
25. Longley BJ Jr, Morganroth GS, Tyrrell I, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307, 1993
26. Luo D, Chen H, Searles G, Jimbow K: Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R. Melanoma Res 5:303-309, 1995
27. Manova K, Huang EJ, Angeles M, et al: The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol 157:85-99, 1993
28. Matous JV, Langley K, Kaushansky K: Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody. Blood 88:437-444, 1996
29. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M: Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853-857, 1994
30. Morstyn G, Brown S, Gordon M, et al: Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology 51:205-214, 1994
31. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Nat Acad Sci USA 92:10560-10564, 1995
32. Natali PG, Nicotra MR, Winkler AB, Cavaliere K, Bigotti A, Ullrich A: Progression of human cutaneous melanoma is associated with loss of expression of c-kit protooncogene receptor. Int J Cancer 52:197-201, 1992
33. Nishikawa S, Kusakabe M, Yosehinaga K, et al: In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J 10:2111-2118, 1991
34. Ohashi A, Funasaka Y, Ueda M, Ichihashi M: C-Kit receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res 6:25-30, 1996
35. Okura M, Maeda H, Nishikawa S, Mizoguchi M: Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol 105:322-328, 1995
36. Reid K, Nishikawa S, Bartlett PF, Murphy M: Steel factor directs melanocyte development in vitro through selective regulation of the number of c-kit+ progenitors. Dev Biol 169:568-579, 1995
37. Rossi P, Dolci S, Albanesi C, Grimaldi P, Ricca K, Geremia R: Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogoma by soluble SLF. Dev Biol 155:68-74, 1993
38. Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E: Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. Am J Pathol 147:1615-1625, 1995
39. Sekido Y, Takahashi T, Ueda R, et al: Recombinant human stem-cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res 53:1709-1714, 1993
40. Shimizu Y, Ashman LR, Du Z, Schwartz LB: Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit. J Immunol 156:3443-3449, 1991
41. Smoller BR, McNutt NS, Hsu A: HMB-45 recognizes stimulated melanocytes. J Cutan Pathol 16:49-53, 1989
42. Smoller BR, Hsu A, Krueger J: HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 18:315-322, 1991
43. Spritz RA, Giebel LB, Holmes SA: Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 50:261-269, 1992
44. Spritz RA, Ho I, Strunk KM: Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting (W). J Invest Dermatol 103:148-150, 1994
45. Takahashi H, Saitoh K, Kishi H, Parsons PG: Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-Kit) in melanocytic tumours. Virchows Arch 427:283-288, 1995
46. Thomson TM, Mattes MJ, Roux I, Old LJ, Lloyd K: Pigmentation-associated glycoprotein of human melanoma and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol 85:169-174, 1985
47. Tsai M, Takeishi T, Thompson H, et al: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem-cell factor. Proc Natl Acad Sci USA 88:6382-6386, 1991
48. Vandenbark G, deCastro C, Taylor H, Dew-Knight S, Kaufman R: Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259-1266, 1992
49. Weiler SR, Mou S, DeBerry CS, et al: JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor. Blood 87:3688-3693, 1996
50. Yarden Y, Kuang W, Yang-Feng T, et al: Human proto-oncogene c-kit a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
51. Yee NS, Langen H, Besmer P: Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J Biol Chem 268:14189-141201, 1993
52. Yoshida H, Kunisada I, Kusakabe M, Nishikawa S, Nishikawa SI: Distinct stages of melanocyte differentiation revealed by analysis of nonuniform pigmentation patterns. Development 122:1207-1214, 1996
53. Zakut R, Perils R, Eliyahu S, Yarden Y, Givol D. Lyman S, Halaban R: KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 8:2221-2229, 1993